Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events

Overview of attention for article published in Clinical Ophthalmology, September 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 18 Mendeley

Summary Policy documents Dimensions citations

So far, Dimensions has found 20 publications that cite this research output.

20

The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.

From Eye Care to Hair Growth: Bimatoprost

Article in Pharmaceuticals (April 2024)

Cytotoxicity, Mitochondrial Functionality, and Redox Status of Human Conjunctival Cells after Short and Chronic Exposure to Preservative-Free Bimatoprost 0.03% and 0.01%: An In Vitro Comparative Study

Article in International Journal of Molecular Sciences (November 2022)

Sovesudil (locally acting rho kinase inhibitor) for the treatment of normal‐tension glaucoma: the randomized phase II study

Article in Acta Ophthalmologica (July 2021)